These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 27042937)

  • 1. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
    Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
    JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.
    So C; Kirby KA; Mehta K; Hoffman RM; Powell AA; Freedland SJ; Sirovich B; Yano EM; Walter LC
    J Gen Intern Med; 2012 Jun; 27(6):653-60. PubMed ID: 22180196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSA screening among elderly men with limited life expectancies.
    Walter LC; Bertenthal D; Lindquist K; Konety BR
    JAMA; 2006 Nov; 296(19):2336-42. PubMed ID: 17105796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year downstream outcomes following prostate-specific antigen screening in older men.
    Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
    JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Value Prostate Cancer Screening Among Older Men Within the Veterans Health Administration.
    Radomski TR; Huang Y; Park SY; Sileanu FE; Thorpe CT; Thorpe JM; Fine MJ; Gellad WF
    J Am Geriatr Soc; 2019 Sep; 67(9):1922-1927. PubMed ID: 31276198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Drazer MW; Huo D; Eggener SE
    J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
    Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
    Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.
    Drazer MW; Huo D; Schonberg MA; Razmaria A; Eggener SE
    J Clin Oncol; 2011 May; 29(13):1736-43. PubMed ID: 21444863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining low-value PSA testing in a large retrospective cohort: Finding common ground between discordant guidelines.
    O'Neil B; Martin C; Kapron A; Flynn M; Kawamoto K; Cooney KA
    Cancer Epidemiol; 2018 Oct; 56():112-117. PubMed ID: 30130683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result.
    Shi Y; Fung KZ; Freedland SJ; Hoffman RM; Tang VL; Walter LC
    Urology; 2014 Nov; 84(5):1058-65. PubMed ID: 25443902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
    Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
    J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities.
    Bryant AK; Lee KM; Alba PR; Murphy JD; Martinez ME; Natarajan L; Green MD; Dess RT; Anglin-Foote TR; Robison B; DuVall SL; Lynch JA; Rose BS
    JAMA Oncol; 2022 Dec; 8(12):1747-1755. PubMed ID: 36279204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National evidence on the use of shared decision making in prostate-specific antigen screening.
    Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
    Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
    Tawfik A
    Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
    Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
    Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Value Prostate-Specific Antigen Screening in Older Males.
    Kalavacherla S; Riviere P; Javier-DesLoges J; Banegas MP; McKay RR; Murphy JD; Rose BS
    JAMA Netw Open; 2023 Apr; 6(4):e237504. PubMed ID: 37040113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.